Abrocitinib for Atopic Dermatitis in Pregnant Women
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Recruiting
Observational Study
Atopic Dermatitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- Pfizer · Industry
Who this trial is looking for
This trial is looking for pregnant women or those who were pregnant recently. Participants will be observed to see how safe the medication abrocitinib is during pregnancy.
Are You a Good Fit for This Trial?
You may be able to join if
- I am currently or recently pregnant.
- I have received at least one dose of abrocitinib during or before my pregnancy.
- I have moderate-to-severe atopic dermatitis at any time before my pregnancy outcome.
- I consent to participate in this study.
- I have signed and dated a consent document.
- I authorize my healthcare provider(s) to share my data.
You may not be able to join if
- I do not meet the inclusion criteria listed above.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this observational study is to learn about the safety of abrocitinib (CIBINQO) in pregnant women and the offspring.
The study is seeking participants who:
* Are currently or recently pregnant
* Receive at least one dose of CIBINQO at any time during pregnancy or prior to pregnancy OR have a diagnosis of moderate-to-severe atopic dermatitis
All participants in this study will rece…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women of any age who are currently or recently pregnant (recently pregnant defined as enrollment within 1 year of pregnancy outcome)
* Consent to participate in this study and evidence of a personally signed and dated informed consent document indicating that the patient (or a…
Contacts